Keith Crandell, Director at Twist Bioscience Corp (TWST), sold 1,339,346 shares at $103.40 ($15.5M) on 2020-12-07, disclosed to the SEC on 2020-12-09.
Open-market sale of $15.5M TWST by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 248,083 | $0 | 0.0% |
| 2 | $0.00 | 497,032 | $0 | 0.0% |
| 3 | $0.00 | 444,231 | $0 | 0.0% |
| 4 | $103.40 | 21,288 | $2.2M | 14.2% |
| 5 | $103.40 | 21,288 | $2.2M | 14.2% |
| 6 | $103.40 | 53,712 |
| $5.6M |
| 35.8% |
| 7 | $103.40 | 53,712 | $5.6M | 35.8% |
| Total | $11.58 avg | 1,339,346 | $15.5M | 100% |
| Filing → |
| DALS | BUY | 2021-08-03 | $16.0M | — | Filing → |
| MASS | BUY | 2020-12-22 | $6.0M | — | Filing → |
| CDAK | BUY | 2020-10-20 | $3.5M | — | Filing → |